About Efedra Pharmaceuticals
Efedra Pharmaceuticals is a Healthcare company based in India. It operates as a pharmaceuticals in the critical care segment are provided, with a focus on formulating affordable medicines that address medical needs. The company has 26 employees. Its Indian entity Efedra Pharmaceuticals Private Limited reported revenue of ₹8.21 Cr. Efedra Pharmaceuticals offers products and services including Critical Care Medicines and Research and Development Services. Its focus areas include Research and Development, Drug Innovation, Clinical Trials and Pharmaceuticals.
Company details
Efedra Pharmaceuticals Private Limited is identified as a fast-growing Indian company in the critical care segment, where affordable and accessible medicines are formulated and delivered to meet critical medical needs. Quality is emphasized through ongoing research and development, alongside commitments to innovation and international standards. The company is dedicated to improving lives of critically ill patients and serving the medical fraternity, while human resource development and employee rewards are prioritized to foster leadership in the sector. Sustainable growth is pursued via scientific rigor and teamwork.
- Headquarters India
- Employees 26
- SectorsHealthcare
- Email••••••••
- Legal Name Efedra Pharmaceuticals Private Limited
- Date of Incorporation 08 Dec, 2017
- Jurisdiction Kolkata, West Bengal, India
- Annual Revenue₹8.21 Cr
FY 2024 · +32% YoY
- Net Profit₹20 Lakh
FY 2024 · 2% margin
- EBITDA₹31.6 Lakh
FY 2024 · 4% margin
- Employee Count26
Associated legal entities of Efedra Pharmaceuticals
Efedra Pharmaceuticals operates through Efedra Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Efedra Pharmaceuticals Private Limited CIN U24239WB2017PTC223778 | Active | 08 Dec 2017 | Kolkata, West Bengal | ₹8.2 Cr | 26 | 3 | View details |
Products & Services of Efedra Pharmaceuticals
Efedra Pharmaceuticals offers a comprehensive portfolio of products and services, including Critical Care Medicines and Research and Development Services.
Affordable medicines for critical medical needs are formulated and delivered to address community health requirements.
Continuous research and development is conducted to fight diseases and ensure sustainable growth in the pharmaceutical sector.
Board of directors of Efedra Pharmaceuticals Private Limited (Efedra Pharmaceuticals)
Efedra Pharmaceuticals Private Limited is the primary company behind Efedra Pharmaceuticals. The board of Efedra Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Arindam Bhattacharya, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arindam Bhattacharya DIN 08016432 | Director | 08 Dec 2017 | 8 yrs 10 mo | Efedra Pharmaceuticals Private Limited |
| Swati Roy DIN 07895154 | Additional Director | 11 Jul 2025 | 1 yr 3 mo | Efedra Pharmaceuticals Private Limited |
| Kaustav Mandal DIN 11358056 | Additional Director | 28 Oct 2025 | 11 mo | Efedra Pharmaceuticals Private Limited |
Financials of Efedra Pharmaceuticals
Figures of Efedra Pharmaceuticals Private Limited, the primary company behind Efedra Pharmaceuticals, for FY 2024. Revenue was ₹8.21 Cr (+32% year on year). Net profit was ₹20 Lakh (2% margin). EBITDA was ₹31.6 Lakh (4% margin). Revenue has grown at a compounded annual rate of +11% over three years and +23% over five years.
- ₹8.21 CrRevenue · FY 2024 · +32% YoY
- ₹20 LakhNet profit · 2% margin
- ₹31.6 LakhEBITDA · 4% margin
- ₹3 LakhPaid-up capital
- 26Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Efedra Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Efedra Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
10 companies that operate in the same segment as Efedra Pharmaceuticals (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | 252 | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Efedra Pharmaceuticals
Efedra Pharmaceuticals is headquartered in India.
Efedra Pharmaceuticals has 26 employees.
The primary company behind Efedra Pharmaceuticals, Efedra Pharmaceuticals Private Limited, reported revenue of ₹8.21 Cr for FY 2024, up 32% year on year.
Efedra Pharmaceuticals Private Limited is identified as a fast-growing Indian company in the critical care segment, where affordable and accessible medicines are formulated and delivered to meet critical medical needs. Quality is emphasized through ongoing research and development, alongside commitments to innovation and international standards. The company is dedicated to improving lives of critically ill patients and serving the medical fraternity, while human resource development and employee rewards are prioritized to foster leadership in the sector. Sustainable growth is pursued via scientific rigor and teamwork.
Efedra Pharmaceuticals offers Critical Care Medicines and Research and Development Services.
Efedra Pharmaceuticals operates through Efedra Pharmaceuticals Private Limited.
The legal entities of Efedra Pharmaceuticals currently have 3 directors, including Arindam Bhattacharya, Swati Roy, Kaustav Mandal.